C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2006
12/28/2006	US20060292177 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
12/28/2006	US20060292175 Chimeric alphavirus replicon particles
12/28/2006	US20060292172 Dengue serotype 1 attenuated strain
12/28/2006	US20060292118 Hollow nanoparticles of protein and drug using the same
12/28/2006	US20060292117 Improved rAAv vectors
12/27/2006	EP1736547A1 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation
12/27/2006	EP1736539A1 Attenuated SARS-CoV vaccines
12/27/2006	EP1736538A1 Process for the preparative purification of virus-like-particles (VLPs)
12/27/2006	EP1734992A2 Improved inactivated fcv vaccines
12/27/2006	EP1163354B1 Compositions and methods for helper-free production of recombinant adeno-associated viruses
12/27/2006	EP1028742B1 Apo b, annexin v and tubulin : medical, diagnostic and purification uses for hcv
12/27/2006	EP1021547B1 Papilloma virus capsomere vaccine formulations and methods of use
12/27/2006	CN1886511A Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus
12/27/2006	CN1884555A Method for preparing phase granule for displaying polypeptide
12/27/2006	CN1884499A Recombinant pig japanese b encephalitis-aujeszkys disease geneticly engineered strain vaccine and its uses
12/27/2006	CN1884498A Recombinant fowl influenza virus strain, its preparation method and the vaccine obtained therefrom
12/27/2006	CN1884497A Reovirus vaccine and its preparing method
12/26/2006	US7153659 Bioassay for measuring the proliferation of T-cells in Human papiloma virus
12/26/2006	US7153513 West nile vaccine
12/26/2006	US7153511 Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine
12/26/2006	US7153510 Recombinant vesiculoviruses and their uses
12/21/2006	WO2006135413A2 Encapsidation system for production of recombinant virus-like particles
12/21/2006	WO2006134917A1 Method for production of antibody
12/21/2006	WO2006134443A1 Dengue serotype 2 attenuated strain
12/21/2006	WO2006133947A1 Highly attenuated pox virus strains, method for the production thereof and the use thereof as paramunity inducers or for producing vector vaccines
12/21/2006	WO2006119096A3 Infectious particle composition and methods of use thereof
12/21/2006	WO2006070371A3 Method for obtaining modified proteins and viruses with intact native binding site
12/21/2006	WO2005027711A3 Capsid-modified adenovirus vectors and methods of using the same
12/21/2006	US20060288449 Process for purifying target compounds from plant sources using ceramic filtration
12/21/2006	US20060288445 P15 hairpin constructs and use
12/21/2006	US20060287230 Compositions which can be used for regulating the activity of parkin
12/21/2006	US20060286667 Mixture of biological cells, used for detection and medical diagnosis of viruses; microbiology; Detecting and differentiating viruses or intracellular parasites present in a specimen; inoculating culture with pathogen and observing for its presence
12/21/2006	US20060286642 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
12/21/2006	DE102005027956A1 Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen Poxvirusstämme highly attenuated, processes for their preparation and their use as paramunity inducers or for the preparation of vector vaccines
12/21/2006	CA2612168A1 Methods for producing antibodies
12/21/2006	CA2611954A1 Dengue serotype 2 attenuated strain
12/21/2006	CA2610277A1 Highly attenuated pox virus strains, method for the production thereof and the use thereof as paramunity inducers or for producing vector vaccines
12/20/2006	EP1734051A2 Composition and methods for the diagnosis of tumours
12/20/2006	EP1732585A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
12/20/2006	EP0964916B1 Hbv mutants and methods for detecting same
12/20/2006	CN1882690A Nucleic acid and gene originating in novel hcv strain and replicon-replicating cell using the gene
12/20/2006	CN1880448A Infectious bursal disease virus VP2 gene expressed recombinant newcastle disease LaSota attenuated vaccine strain
12/20/2006	CN1291012C Altered strain of modified vaccinia virus ankara (MVA)
12/19/2006	US7151172 virion infectivity factor (vif) proteins; use in vaccine against the HIV-1 virus
12/19/2006	US7150984 Attenuated human rotavirus vaccine
12/19/2006	US7150874 NUCLEIC ACID SEQUENCE USEFUL FOR INSERTION VIA HOMOLOGOUS RECOMBINATION; recombinant poxviruses carrying heterologous coding sequences transferred by DNA vector
12/14/2006	WO2006132605A2 Porcine circovirus type 2 vaccines
12/14/2006	WO2006132598A1 Porcine circovirus type 2 vaccines
12/14/2006	US20060281075 Purification of viruses, proteins and nucleic acids
12/14/2006	US20060280758 Modified vaccinia ankara virus variant
12/14/2006	US20060280757 Flavivirus vaccine delivery system
12/14/2006	US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
12/14/2006	CA2595923A1 Methods for identifying compounds that inhibit hiv infection
12/13/2006	EP1731612A1 Recombinant herpesvirus and utilization of the same
12/13/2006	EP1731599A1 Method of constructing recombinant herpes simplex virus
12/13/2006	EP1731598A1 Methods for cultivating cells and propagating viruses
12/13/2006	EP1731166A2 Streptococcus pneumoniae proteins and vaccines
12/13/2006	EP1730175A1 Optimized expression of hpv 52 l1 in yeast
12/13/2006	EP1343896B1 Small acid-soluble spore protein and uses thereof
12/13/2006	EP1121441B1 Selectively replicating viral vectors
12/13/2006	EP0968284B1 An improved method for the production and purification of adenoviral vectors
12/13/2006	CN1289682C Expression of genes in modified vaccinia virus ankara by using the cowpox ATI promoter
12/13/2006	CN1289663C Method for the recovery and purification of poxviruses from infected cells
12/13/2006	CN1289098C Vesicular stromatitis virus (VSV)
12/12/2006	US7148341 Adenovirus associated nucleotide sequences; for use as gene transfer tool in genetic engineerinf in the
12/12/2006	US7148202 Receptor-mediated gene delivery using bacteriophage vectors
12/12/2006	US7147848 Administering hybrid polio viruse to tumor, cancer
12/12/2006	CA2167080C Prrsv recombinant proteins, diagnostic kits and vaccines containing prrs recombinant proteins
12/12/2006	CA2153336C Recombinant virus immunotherapy
12/12/2006	CA2105277C Genetically engineered vaccine strain
12/07/2006	WO2006129139A1 N protein mutants of porcine reproductive and respiratory syndrome virus
12/07/2006	WO2006129092A2 Use of bacteriophage in medicaments
12/07/2006	WO2005115448A3 Multi plasmid system for the production of influenza virus
12/07/2006	WO2004003153A3 Live replicating spumavirus vector
12/07/2006	US20060275796 Canine herpesvirus thymidine kinase nucleic acid molecules
12/07/2006	US20060275774 Negative strand rna virus replicon
12/07/2006	US20060275323 Particles of HCV envelope proteins: use for vaccination
12/07/2006	CA2610164A1 Novel glutamic acid decarboxylase (gad) chimera and methods of use
12/07/2006	CA2599322A1 N protein mutants of porcine reproductive and respiratory syndrome virus
12/06/2006	EP1728800A1 Papilloma virus-like particles, fusion proteins and process for producing the same
12/06/2006	EP1727915A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/06/2006	EP1727894A1 Cellular and viral inactivation
12/06/2006	EP1727423A1 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals
12/06/2006	EP1166797B1 Method for quality control of an attenuated varicella live vaccine
12/06/2006	EP0910406B1 Recombinant canine herpesviruses
12/06/2006	CN1875028A Seneca valley virus based compositions and methods for treating disease
12/06/2006	CN1872994A 感染性克隆 Infectious clone
12/06/2006	CN1288241C Method for increasing insect virus propagation efficiency
12/06/2006	CN1287850C Vaccines, immunotherapeutics and methods for using same
12/05/2006	US7144578 Mixture of attenuated genetic engineered virus and carrier
12/05/2006	CA2141422C Recombinant equine herpesviruses
11/2006
11/30/2006	WO2006127956A2 Rapid production of adenovirus-free recombinant adenovirus vectors
11/30/2006	WO2006100060A3 Colloidal nanocomposites comprising lbl-particles, lipids and biological components and method for the production thereof
11/30/2006	WO2006058031A3 Microarray quality control
11/30/2006	US20060270031 Cell separation method and kit using phase separation
11/30/2006	US20060270017 Inactivation of a pathogen in a sample by a treatment with formalin and UV light
11/30/2006	US20060270016 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
11/30/2006	US20060270005 Genomic library of cyanophage s-2l and functional analysis
11/30/2006	US20060269954 Self-assembling recombinant papillomavirus capsid proteins
11/30/2006	US20060269570 Recombinant double-stranded RNA phage, and use of the same

1 ... 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 ... 267